344 related articles for article (PubMed ID: 1671719)
21. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
Tenenbaum F; Lumbroso J; Schlumberger M; Mure A; Plouin PF; Caillou B; Parmentier C
J Nucl Med; 1995 Jan; 36(1):1-6. PubMed ID: 7799058
[TBL] [Abstract][Full Text] [Related]
22. Comparison of iodobenzylguanidine imaging with computed tomography in locating pheochromocytoma.
Chatal JF; Charbonnel B
J Clin Endocrinol Metab; 1985 Oct; 61(4):769-72. PubMed ID: 4031017
[TBL] [Abstract][Full Text] [Related]
23. [Localization of pheochromocytomas by 131-I-meta-iodobenzylguanidine scintigraphy].
Dupont J; Fleury-Goyon MC; Lahnèche B; Mornex R
Ann Med Interne (Paris); 1991; 142(3):171-6. PubMed ID: 1854129
[TBL] [Abstract][Full Text] [Related]
24. [131I-meta-iodobenzylguanidine scintigraphy in patients with a suspected pheochromocytoma. A comparison with CT and biohumoral parameters].
Maurelli L; Cuocolo A; Lastoria S; Brunetti A; Maurea S; Lembo G; Klain M; Caracò C; Salvatore M
Radiol Med; 1991 Dec; 82(6):839-43. PubMed ID: 1788441
[TBL] [Abstract][Full Text] [Related]
25. [Familial pheochromocytoma in Sipple's syndrome. A comparison between scintigraphy with 131I-meta-iodobenzylguanidine, computed tomography and echography].
Maurea S; Maurelli L; Lastoria S; Cuocolo A; Brunetti A; Pace L; Caracò C; Klain M; Lupoli G; Salvatore M
Radiol Med; 1992 Apr; 83(4):486-90. PubMed ID: 1351307
[No Abstract] [Full Text] [Related]
26. Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
Maurea S; Caracò C; Klain M; Mainolfi C; Salvatore M
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):188-97. PubMed ID: 15499292
[TBL] [Abstract][Full Text] [Related]
27. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
[TBL] [Abstract][Full Text] [Related]
28. Pheochromocytoma and the normal adrenal medulla: improved visualization with I-123 MIBG scintigraphy.
Lynn MD; Shapiro B; Sisson JC; Beierwaltes WH; Meyers LJ; Ackerman R; Mangner TJ
Radiology; 1985 Jun; 155(3):789-92. PubMed ID: 4001380
[TBL] [Abstract][Full Text] [Related]
29. [Diagnosis of pheochromocytoma by 131I-MIBG scintigraphy].
Miyanaga N; Hattori K; Shiraiwa H; Hinotsu S; Nemoto R; Koiso K; Takeda T; Ishikawa N
Hinyokika Kiyo; 1990 Feb; 36(2):105-8. PubMed ID: 2343801
[TBL] [Abstract][Full Text] [Related]
30. Value of 123I-MIBG Scintigraphy in Paraganglioma.
Milardovic R; Corssmit EP; Stokkel M
Neuroendocrinology; 2010; 91(1):94-100. PubMed ID: 19786729
[TBL] [Abstract][Full Text] [Related]
31. 99mTc-HYNIC-TOC scintigraphy is superior to 131I-MIBG imaging in the evaluation of extraadrenal pheochromocytoma.
Chen L; Li F; Zhuang H; Jing H; Du Y; Zeng Z
J Nucl Med; 2009 Mar; 50(3):397-400. PubMed ID: 19223405
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of Somatostatin Receptor Scintigraphy (Tc-[HYNIC, Tyr3]-Octreotide) and 123I-Metaiodobenzylguanidine Scintigraphy in Patients with SDHx Gene-Related Pheochromocytomas and Paragangliomas Detected by Computed Tomography.
Michałowska I; Ćwikła JB; Pęczkowska M; Furmanek MI; Buscombe JR; Michalski W; Prejbisz A; Szperl M; Malinoc A; Moczulski D; Szutkowski Z; Kawecki A; Antoniewicz J; Pęczkowski P; Lewczuk A; Otto M; Cichocki A; Bednarek-Tupikowska G; Kabat M; Janaszek-Sitkowska H; Przybyłowska K; Janas J; Neumann HP; Januszewicz A
Neuroendocrinology; 2015; 101(4):321-30. PubMed ID: 25791839
[TBL] [Abstract][Full Text] [Related]
33. The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy.
Nakajo M; Shapiro B; Copp J; Kalff V; Gross MD; Sisson JC; Beierwaltes WH
J Nucl Med; 1983 Aug; 24(8):672-82. PubMed ID: 6135764
[TBL] [Abstract][Full Text] [Related]
34. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
[TBL] [Abstract][Full Text] [Related]
35. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?
Taïeb D; Sebag F; Hubbard JG; Mundler O; Henry JF; Conte-Devolx B
Clin Endocrinol (Oxf); 2004 Jul; 61(1):102-8. PubMed ID: 15212651
[TBL] [Abstract][Full Text] [Related]
36. [A case of multiple extra-adrenal pheochromocytoma diagnosed by [131I] meta-iodobenzylguanidine [( 131I] MIBG) scintigraphy and nuclear magnetic resonance (NMR)].
Sasaki J; Yamada H; Fujisawa T; Kawahara Y; Ishikawa Y; Yokota Y; Fujitani K; Furuta Y; Ito Y; Fukuzaki H
Nihon Naika Gakkai Zasshi; 1986 Aug; 75(8):1102-8. PubMed ID: 3783007
[No Abstract] [Full Text] [Related]
37. Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas.
Havekes B; van der Klaauw AA; Weiss MM; Jansen JC; van der Mey AG; Vriends AH; Bonsing BA; Romijn JA; Corssmit EP
Endocr Relat Cancer; 2009 Jun; 16(2):527-36. PubMed ID: 19289533
[TBL] [Abstract][Full Text] [Related]
38. MR imaging of the adrenal gland in Sipple disease.
Mathieu E; Despres E; Delepine N; Taieb A
J Comput Assist Tomogr; 1987; 11(5):790-4. PubMed ID: 2888797
[TBL] [Abstract][Full Text] [Related]
39. [Clinical applications of 131I-meta iodobenzylguanidine (131I-MIBG) scintigraphy in Japan].
Izumi M; Kakezono F; Nagayama Y; Kiriyama T; Yokoyama N; Yamashita S; Morita S; Hirayu H; Kubo I; Ohtakara S
Kaku Igaku; 1986 Feb; 23(2):145-52. PubMed ID: 2872353
[No Abstract] [Full Text] [Related]
40. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
Rufini V; Treglia G; Castaldi P; Perotti G; Calcagni ML; Corsello SM; Galli G; Fanti S; Giordano A
Nucl Med Commun; 2011 Jul; 32(7):575-82. PubMed ID: 21471850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
